Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Bruce M, Jones"'
Autor:
Nicholas Rebold, Sara Alosaimy, Jeffrey C. Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T. Anderson, Monica V. Mahoney, Wesley D. Kufel, Joseph A. D’Antonio, Bruce M. Jones, Jeremy J. Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P. Veve, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 3, Pp 565-579 (2024)
Abstract Introduction Long-acting lipoglycopeptides such as dalbavancin may have utility in patients with Gram-positive bloodstream infections (BSI), particularly in those with barriers to discharge or who require prolonged parenteral antibiotic cour
Externí odkaz:
https://doaj.org/article/329fe8cb8de8423a9b5e528288ac79f6
Autor:
Y. Vivian Tsai, P. Brandon Bookstaver, Joseph Kohn, Julie Ann Justo, Darrell Childress, Stefanie Stramel, Douglas Slain, Patrick Tu, Mary Joyce B. Wingler, Bruce M. Jones, Daniel T. Anderson, Megan M. Seddon, David A. Cretella, Joshua Eudy, Hana Winders, Kayla Antosz, Pamela Bailey, Majdi N. Al-Hasan
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 4 (2024)
Abstract Objective: To evaluate temporal trends in the prevalence of gram-negative bacteria (GNB) with difficult-to-treat resistance (DTR) in the southeastern United States. Secondary objective was to examine the use of novel β-lactams for GNB with
Externí odkaz:
https://doaj.org/article/e9d03f5949bf4cea9d5f80964311c880
Autor:
Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Abdalhamid M. Lagnf, Taylor Morrisette, Kyle C. Molina, Alaina DeKerlegand, Melanie Rae Schrack, S. Lena Kang-Birken, Athena L.V. Hobbs, Jazmin Agee, Nicholson B. Perkins, Mark Biagi, Michael Pierce, James Truong, Justin Andrade, Jeannette Bouchard, Tristan Gore, Madeline A. King, Benjamin M. Pullinger, Kimberly C. Claeys, Shelbye Herbin, Reese Cosimi, Serina Tart, Michael P. Veve, Bruce M. Jones, Leonor M. Rojas, Amy K. Feehan, Marco R. Scipione, Jing J. Zhao, Paige Witucki, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 1 (2024)
ABSTRACT Eravacycline is a synthetic fluorocycline approved by the U.S. Food and Drug Administration in 2018. This study aimed to describe clinical and microbiological outcomes in addition to associated adverse effects of eravacycline used in U.S. ho
Externí odkaz:
https://doaj.org/article/c7670c6ad2ab4a279e5ee3917f0e0369
Autor:
Bruce M. Jones, Kerry O. Cleveland, Pedro L. Gonzalez, Urania Rappo, Todd Riccobene, Rosie D. Lyles
Publikováno v:
Clinical Infection in Practice, Vol 21, Iss , Pp 100251- (2024)
Objectives: Dalbavancin has potent activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, and is approved for treatment of acute bacterial skin and skin structure infections (ABSSSI). We describe real-world u
Externí odkaz:
https://doaj.org/article/cc2342e144c14f8da6cd40dcecc7cba9
Autor:
Bruce M. Jones, Jamie L. Wagner, Daniel B. Chastain, P. Brandon Bookstaver, Kayla Stover, Jason Lin, Hannah Matson, Noah White, Madalyn Motesh, Christopher M. Bland
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 28, Iss , Pp 282-287 (2022)
Background: Stenotrophomonas maltophilia is a cause of infection most commonly in the opportunistic host. Trimethoprim-sulfamethoxazole and levofloxacin are considered first-line treatment agents. With reports of increasing resistance to these first-
Externí odkaz:
https://doaj.org/article/7d7e7e2a17294ec3896145f2f01eea37
Autor:
Adam G. Pizzuti, E. Yancy Murray, Jamie L. Wagner, Derek A. Gaul, Christopher M. Bland, Bruce M. Jones
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 1043-1053 (2020)
Abstract Introduction Acute bacterial skin and skin structure infections (ABSSSI) are an increasing cause of admission in the self-pay population. We previously reported that patients with ABSSSI discharged to receive dalbavancin showed a decreased l
Externí odkaz:
https://doaj.org/article/88e11c3e27844d7f94e706cadcf17e7a
Publikováno v:
IDCases, Vol 25, Iss , Pp e01166- (2021)
Eosinophilic pneumonia (EP) is characterized by accumulation of eosinophils in the lungs and has been associated with several medications, including antimicrobials. Cefepime is a commonly used broad-spectrum antimicrobial agent for the treatment of n
Externí odkaz:
https://doaj.org/article/0448b57b00814452a7517c5e4e0397d9
Publikováno v:
Pharmacy, Vol 9, Iss 3, p 141 (2021)
Fluoroquinolones are associated with an increased risk of Clostridioides difficile infection (CDI). Probiotic supplementation has been shown to reduce the risk of antibiotic-associated diarrhea with variable effects on CDI. The objective of this stud
Externí odkaz:
https://doaj.org/article/45ef4e9d429f488986ba4f57f252bff2
Autor:
Mary Joyce B. Wingler, David A. Cretella, Jamie L. Wagner, Katie E. Barber, P. Brandon Bookstaver, Lauren Freeman, Elizabeth W. Covington, Christopher M. Bland, Bruce M. Jones, Maicuc Tran, Stefanie A. Stramel, Michelle Turner, Darrell Childress, Kayla R. Stover
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6:241-251
Due to the COVID-19 pandemic, most pharmacy residency programs changed to an all-virtual format for recruitment and interviews for the 2020-2021 application cycle. There are no data evaluating the experiences and perceptions of these changes from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::629c6fbbf1821e576d5ffa218adcfb1e
https://doi.org/10.1002/jac5.1684
https://doi.org/10.1002/jac5.1684
Autor:
Mary L Staicu, Meghan N Jeffres, Bruce M Jones, Kayla R Stover, Jamie L Wagner, Christopher M Bland
Publikováno v:
JAC-Antimicrobial Resistance. 5
BackgroundThe clinical and financial consequences associated with a penicillin-allergy label are increasingly evident and have garnered support from international organizations to prioritize penicillin-allergy delabelling programmes. Most settings la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7e97b96ee936a0b46f8f8f02a804e10
https://doi.org/10.1093/jacamr/dlad014
https://doi.org/10.1093/jacamr/dlad014